Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

May 10, 2011

30339_dirs_2011-05-10_26f41eeb-579e-466e-8f19-dfb37d88cdfa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-05-10

Reporting Person: Paproski John E (President-Delivery Systems)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-10 Common Stock M 9000.0000 $14.4100 Acquired 34086.5155 Direct
2011-05-10 Common Stock S 9000.0000 $46.9261 Disposed 25086.5155 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-10 Stock Option (Right to Buy) $14.4100 M 9000.0000 Disposed 2012-03-08 Common Stock (9000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6463.9034 Indirect
Common Stock 2449.1689 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.